Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1981 3
1982 1
1983 2
1984 3
1987 3
1988 1
1989 2
1990 2
1991 4
1992 6
1993 3
1994 1
1995 3
1996 4
1997 4
1998 5
1999 4
2000 7
2001 1
2002 2
2003 3
2004 2
2005 5
2006 6
2007 7
2008 4
2009 3
2010 8
2011 6
2012 7
2013 4
2014 8
2015 5
2016 8
2017 7
2018 12
2019 12
2020 11
2021 7
2022 12
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 3
Incidence, time to occurrence and predictors of peripheral intravenous cannula-related complications among neonates and infants in Northwest Ethiopia: an institutional-based prospective study.
Baye ND, Teshome AA, Ayenew AA, Amare TJ, Mulu AT, Abebe EC, Tiruneh GA, Ayele TM, Muche ZT, Teklemariam AB, Melese BD, Agidew MM, Seid MA. Baye ND, et al. BMC Nurs. 2023 Jan 11;22(1):11. doi: 10.1186/s12912-022-01164-x. BMC Nurs. 2023. PMID: 36631864 Free PMC article.
BACKGROUND: Peripheral intravenous cannulas (PIVC) are venous access devices commonly used for the administration of intravenous fluids, drugs, blood products, and parenteral nutrition. ...Anatomical insertion site (AHR = 2.85, 95%CI: 1.63-6.27), admis …
BACKGROUND: Peripheral intravenous cannulas (PIVC) are venous access devices commonly used for the administration of …
Heparin for prolonging peripheral intravenous catheter use in neonates: a randomized controlled trial.
Upadhyay A, Verma KK, Lal P, Chawla D, Sreenivas V. Upadhyay A, et al. J Perinatol. 2015 Apr;35(4):274-7. doi: 10.1038/jp.2014.203. Epub 2014 Dec 4. J Perinatol. 2015. PMID: 25474552 Clinical Trial.
OBJECTIVE: To determine the efficacy of heparinized saline administered as intermittent flush on functional duration of the peripheral intravenous catheter (PIVC) in neonates. ...CONCLUSION: Heparinized saline flush increases the functional dura …
OBJECTIVE: To determine the efficacy of heparinized saline administered as intermittent flush on functional duration of the periph …
Correlation between visual inspection/physical exam and point-of-care ultrasound exam in the evaluation of neonatal peripheral intravenous catheter site.
Frunza IF, Boyar V, Fishbein J, Kurepa D. Frunza IF, et al. J Matern Fetal Neonatal Med. 2022 Dec;35(25):8552-8558. doi: 10.1080/14767058.2021.1988564. Epub 2021 Oct 10. J Matern Fetal Neonatal Med. 2022. PMID: 34632914
BACKGROUND: A peripheral intravenous catheter (PIVC) is used to administer IV fluids and medications. The most common PIVC complication is peripheral intravenous extravasation and infiltration (PIVE/I). Early visual inspection and physical exam …
BACKGROUND: A peripheral intravenous catheter (PIVC) is used to administer IV fluids and medications. The most common P …
Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug administration in newborn infants.
Flint A, McIntosh D, Davies MW. Flint A, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004593. doi: 10.1002/14651858.CD004593.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235368 Review.
BACKGROUND: The use of peripheral intravenous cannulae is common in newborn babies. Many of them require an intravenous line only for medications and not for fluid. ...SELECTION CRITERIA: Randomised controlled trials comparing continuous infusion …
BACKGROUND: The use of peripheral intravenous cannulae is common in newborn babies. Many of them require an intraven …
Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.
Grant SM, Goa KL. Grant SM, et al. Drugs. 1992 Jun;43(6):889-924. doi: 10.2165/00003495-199243060-00008. Drugs. 1992. PMID: 1379160 Review.
Improved metabolic and, in particular, chemical stability enhance the clinical utility of iloprost. When administered as an intermittent intravenous infusion at less than or equal to 2 ng/kg/min for 2 to 4 weeks, iloprost reduced rest pain and improved ulcer healing …
Improved metabolic and, in particular, chemical stability enhance the clinical utility of iloprost. When administered as an intermittent …
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Murdoch D, Brogden RN. Murdoch D, et al. Drugs. 1991 May;41(5):737-79. doi: 10.2165/00003495-199141050-00006. Drugs. 1991. PMID: 1712708 Review.
The exact mechanism of action of nifedipine in all of these disorders has not been defined. However, its potent peripheral and coronary arterial dilator properties, together with improvements in oxygen supply/demand, are of particular importance. ...Adverse effects seem to …
The exact mechanism of action of nifedipine in all of these disorders has not been defined. However, its potent peripheral and corona …
Use of 8-cm 22G-long peripheral cannulas in pediatric patients.
Pacilli M, Bradshaw CJ, Clarke SA. Pacilli M, et al. J Vasc Access. 2018 Sep;19(5):496-500. doi: 10.1177/1129729818761278. Epub 2018 Mar 12. J Vasc Access. 2018. PMID: 29529968
INTRODUCTION: Medium-term intravenous access in children is normally achieved by means of repeated multiple peripheral intravenous cannula insertions or peripherally inserted central catheters. ...Our aim was to clarify whether long pe …
INTRODUCTION: Medium-term intravenous access in children is normally achieved by means of repeated multiple peripheral intr …
Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J, Marjanovic N, Drugeon B, Neill RO, Liuu E, Roblot F, Palazzo P, Bironneau V, Prevost F, Paul J, Pichon M, Boisson M, Frasca D, Mimoz O; CLEAN-3 trial investigators. Guenezan J, et al. Lancet Infect Dis. 2021 Jul;21(7):1038-1048. doi: 10.1016/S1473-3099(20)30738-6. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539734 Clinical Trial.
BACKGROUND: Two billion peripheral venous catheters are sold globally each year, but the optimal skin disinfection and types of devices are not well established. We aimed to show the superiority of disinfection with 2% chlorhexidine plus alcohol over 5% povidone iod …
BACKGROUND: Two billion peripheral venous catheters are sold globally each year, but the optimal skin disinfection and types o …
Mock drug delivery to the proximal aorta during cardiopulmonary resuscitation: central vs peripheral intravenous infusion with varying flush volumes.
Gaddis GM, Dolister M, Gaddis ML. Gaddis GM, et al. Acad Emerg Med. 1995 Dec;2(12):1027-33. doi: 10.1111/j.1553-2712.1995.tb03143.x. Acad Emerg Med. 1995. PMID: 8597912 Free article.
OBJECTIVE: To compare mock drug deliveries to the proximal aorta during CPR after peripheral vs central i.v. administration when the mock drug is followed by different postinfusion flush volumes. ...The ICG administration (2.5 mg) preceded either a 2-mL or a 10-mL s …
OBJECTIVE: To compare mock drug deliveries to the proximal aorta during CPR after peripheral vs central i.v. administration when the …
Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
Melian EB, Goa KL. Melian EB, et al. Drugs. 2002;62(1):107-33. doi: 10.2165/00003495-200262010-00005. Drugs. 2002. PMID: 11790158 Review.
Data from a large, randomised, double-blind, multicentre study indicated that beraprost was as efficacious as ticlopidine in the treatment of patients with peripheral arterial disease (Buerger's disease and arteriosclerosis obliterans). ...Beraprost is a well tolerated age …
Data from a large, randomised, double-blind, multicentre study indicated that beraprost was as efficacious as ticlopidine in the treatment o …
193 results